The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2025

Global Adipose Tissue-derived Stem Cell Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1911327

No of Pages : 93

Ask Your Query

Synopsis

Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.

The global Adipose Tissue-derived Stem Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Adipose Tissue-derived Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Adipose Tissue-derived Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Adipose Tissue-derived Stem Cell Therapy include AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast and Pluristem Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Adipose Tissue-derived Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Tissue-derived Stem Cell Therapy.

Report Scope

The Adipose Tissue-derived Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adipose Tissue-derived Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adipose Tissue-derived Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • AlloCure
  • Antria
  • Celgene Corporation
  • Cellleris
  • Corestem
  • Cytori Therapeutics
  • Intrexon
  • Mesoblast
  • Pluristem Therapeutics
  • Tissue Genesis
  • BioRestorative Therapies
  • Celltex Therapeutics Corporation
  • iXCells Biotechnologies
  • Pluristem Therapeutics
  • Cyagen
  • Lonza

Segment by Type

  • Autologous Stem Cells
  • Allogeneic Stem Cells

Segment by Application

  • Therapeutic Application
  • Research Application

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adipose Tissue-derived Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous Stem Cells
1.2.3 Allogeneic Stem Cells
1.3 Market by Application
1.3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Therapeutic Application
1.3.3 Research Application
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Perspective (2019-2030)
2.2 Adipose Tissue-derived Stem Cell Therapy Growth Trends by Region
2.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Adipose Tissue-derived Stem Cell Therapy Market Dynamics
2.3.1 Adipose Tissue-derived Stem Cell Therapy Industry Trends
2.3.2 Adipose Tissue-derived Stem Cell Therapy Market Drivers
2.3.3 Adipose Tissue-derived Stem Cell Therapy Market Challenges
2.3.4 Adipose Tissue-derived Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue
3.1.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adipose Tissue-derived Stem Cell Therapy Revenue
3.4 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adipose Tissue-derived Stem Cell Therapy Revenue in 2023
3.5 Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Type
4.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Adipose Tissue-derived Stem Cell Therapy Breakdown Data by Application
5.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size (2019-2030)
6.2 North America Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AlloCure
11.1.1 AlloCure Company Detail
11.1.2 AlloCure Business Overview
11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Introduction
11.1.4 AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.1.5 AlloCure Recent Development
11.2 Antria
11.2.1 Antria Company Detail
11.2.2 Antria Business Overview
11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Introduction
11.2.4 Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.2.5 Antria Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Detail
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.3.4 Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.3.5 Celgene Corporation Recent Development
11.4 Cellleris
11.4.1 Cellleris Company Detail
11.4.2 Cellleris Business Overview
11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Introduction
11.4.4 Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.4.5 Cellleris Recent Development
11.5 Corestem
11.5.1 Corestem Company Detail
11.5.2 Corestem Business Overview
11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Introduction
11.5.4 Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.5.5 Corestem Recent Development
11.6 Cytori Therapeutics
11.6.1 Cytori Therapeutics Company Detail
11.6.2 Cytori Therapeutics Business Overview
11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.6.4 Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.6.5 Cytori Therapeutics Recent Development
11.7 Intrexon
11.7.1 Intrexon Company Detail
11.7.2 Intrexon Business Overview
11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Introduction
11.7.4 Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.7.5 Intrexon Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Detail
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Detail
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.9.5 Pluristem Therapeutics Recent Development
11.10 Tissue Genesis
11.10.1 Tissue Genesis Company Detail
11.10.2 Tissue Genesis Business Overview
11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Introduction
11.10.4 Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.10.5 Tissue Genesis Recent Development
11.11 BioRestorative Therapies
11.11.1 BioRestorative Therapies Company Detail
11.11.2 BioRestorative Therapies Business Overview
11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Introduction
11.11.4 BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.11.5 BioRestorative Therapies Recent Development
11.12 Celltex Therapeutics Corporation
11.12.1 Celltex Therapeutics Corporation Company Detail
11.12.2 Celltex Therapeutics Corporation Business Overview
11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
11.12.4 Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.12.5 Celltex Therapeutics Corporation Recent Development
11.13 iXCells Biotechnologies
11.13.1 iXCells Biotechnologies Company Detail
11.13.2 iXCells Biotechnologies Business Overview
11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Introduction
11.13.4 iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.13.5 iXCells Biotechnologies Recent Development
11.14 Pluristem Therapeutics
11.14.1 Pluristem Therapeutics Company Detail
11.14.2 Pluristem Therapeutics Business Overview
11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
11.14.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.14.5 Pluristem Therapeutics Recent Development
11.15 Cyagen
11.15.1 Cyagen Company Detail
11.15.2 Cyagen Business Overview
11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Introduction
11.15.4 Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.15.5 Cyagen Recent Development
11.16 Lonza
11.16.1 Lonza Company Detail
11.16.2 Lonza Business Overview
11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Introduction
11.16.4 Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
11.16.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Autologous Stem Cells
Table 3. Key Players of Allogeneic Stem Cells
Table 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2019-2024)
Table 8. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2025-2030)
Table 10. Adipose Tissue-derived Stem Cell Therapy Market Trends
Table 11. Adipose Tissue-derived Stem Cell Therapy Market Drivers
Table 12. Adipose Tissue-derived Stem Cell Therapy Market Challenges
Table 13. Adipose Tissue-derived Stem Cell Therapy Market Restraints
Table 14. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players (2019-2024)
Table 16. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2023)
Table 17. Ranking of Global Top Adipose Tissue-derived Stem Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. AlloCure Company Detail
Table 47. AlloCure Business Overview
Table 48. AlloCure Adipose Tissue-derived Stem Cell Therapy Product
Table 49. AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 50. AlloCure Recent Development
Table 51. Antria Company Detail
Table 52. Antria Business Overview
Table 53. Antria Adipose Tissue-derived Stem Cell Therapy Product
Table 54. Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 55. Antria Recent Development
Table 56. Celgene Corporation Company Detail
Table 57. Celgene Corporation Business Overview
Table 58. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product
Table 59. Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 60. Celgene Corporation Recent Development
Table 61. Cellleris Company Detail
Table 62. Cellleris Business Overview
Table 63. Cellleris Adipose Tissue-derived Stem Cell Therapy Product
Table 64. Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 65. Cellleris Recent Development
Table 66. Corestem Company Detail
Table 67. Corestem Business Overview
Table 68. Corestem Adipose Tissue-derived Stem Cell Therapy Product
Table 69. Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 70. Corestem Recent Development
Table 71. Cytori Therapeutics Company Detail
Table 72. Cytori Therapeutics Business Overview
Table 73. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 74. Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 75. Cytori Therapeutics Recent Development
Table 76. Intrexon Company Detail
Table 77. Intrexon Business Overview
Table 78. Intrexon Adipose Tissue-derived Stem Cell Therapy Product
Table 79. Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 80. Intrexon Recent Development
Table 81. Mesoblast Company Detail
Table 82. Mesoblast Business Overview
Table 83. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product
Table 84. Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 85. Mesoblast Recent Development
Table 86. Pluristem Therapeutics Company Detail
Table 87. Pluristem Therapeutics Business Overview
Table 88. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 89. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 90. Pluristem Therapeutics Recent Development
Table 91. Tissue Genesis Company Detail
Table 92. Tissue Genesis Business Overview
Table 93. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product
Table 94. Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 95. Tissue Genesis Recent Development
Table 96. BioRestorative Therapies Company Detail
Table 97. BioRestorative Therapies Business Overview
Table 98. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product
Table 99. BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 100. BioRestorative Therapies Recent Development
Table 101. Celltex Therapeutics Corporation Company Detail
Table 102. Celltex Therapeutics Corporation Business Overview
Table 103. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product
Table 104. Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 105. Celltex Therapeutics Corporation Recent Development
Table 106. iXCells Biotechnologies Company Detail
Table 107. iXCells Biotechnologies Business Overview
Table 108. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product
Table 109. iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 110. iXCells Biotechnologies Recent Development
Table 111. Pluristem Therapeutics Company Detail
Table 112. Pluristem Therapeutics Business Overview
Table 113. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product
Table 114. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 115. Pluristem Therapeutics Recent Development
Table 116. Cyagen Company Detail
Table 117. Cyagen Business Overview
Table 118. Cyagen Adipose Tissue-derived Stem Cell Therapy Product
Table 119. Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 120. Cyagen Recent Development
Table 121. Lonza Company Detail
Table 122. Lonza Business Overview
Table 123. Lonza Adipose Tissue-derived Stem Cell Therapy Product
Table 124. Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 125. Lonza Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adipose Tissue-derived Stem Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type: 2023 VS 2030
Figure 3. Autologous Stem Cells Features
Figure 4. Allogeneic Stem Cells Features
Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2023 VS 2030
Figure 7. Therapeutic Application Case Studies
Figure 8. Research Application Case Studies
Figure 9. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Region: 2023 VS 2030
Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players in 2023
Figure 14. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2023
Figure 16. North America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2019-2030)
Figure 18. United States Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2019-2030)
Figure 22. Germany Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Share by Region (2019-2030)
Figure 30. China Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2019-2030)
Figure 38. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Share by Country (2019-2030)
Figure 42. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. AlloCure Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 45. Antria Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 46. Celgene Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 47. Cellleris Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 48. Corestem Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 49. Cytori Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 50. Intrexon Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 51. Mesoblast Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 52. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 53. Tissue Genesis Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 54. BioRestorative Therapies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 55. Celltex Therapeutics Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 56. iXCells Biotechnologies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 57. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 58. Cyagen Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 59. Lonza Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock